These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 38239049)

  • 81. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.
    Holler E; Butzhammer P; Schmid K; Hundsrucker C; Koestler J; Peter K; Zhu W; Sporrer D; Hehlgans T; Kreutz M; Holler B; Wolff D; Edinger M; Andreesen R; Levine JE; Ferrara JL; Gessner A; Spang R; Oefner PJ
    Biol Blood Marrow Transplant; 2014 May; 20(5):640-5. PubMed ID: 24492144
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Gut-microbiota derived bioactive metabolites and their functions in host physiology.
    Debnath N; Kumar R; Kumar A; Mehta PK; Yadav AK
    Biotechnol Genet Eng Rev; 2021 Oct; 37(2):105-153. PubMed ID: 34678130
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation.
    Kusakabe S; Fukushima K; Maeda T; Motooka D; Nakamura S; Fujita J; Yokota T; Shibayama H; Oritani K; Kanakura Y
    Br J Haematol; 2020 Feb; 188(3):438-449. PubMed ID: 31566729
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Faecal microbiota transplantation in patients with haematological malignancies undergoing cellular therapies: from translational research to routine clinical practice.
    Malard F; Gaugler B; Mohty M
    Lancet Haematol; 2022 Oct; 9(10):e776-e785. PubMed ID: 36174640
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease.
    Lee SE; Lim JY; Ryu DB; Kim TW; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Kim CS; Shin DM; Min CK
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):1933-1943. PubMed ID: 31195137
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Clinical study of 19 cases of steroid-refractory gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with fecal microbiota transplantation].
    Zheng YY; Yang XT; Lin GQ; Bian MR; Si YJ; Zhang XX; Zhang YM; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):401-407. PubMed ID: 37550190
    [No Abstract]   [Full Text] [Related]  

  • 87. Role of the intestinal mucosa in acute gastrointestinal GVHD.
    Peled JU; Hanash AM; Jenq RR
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):119-127. PubMed ID: 27913470
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Role of Intestinal Microbiota in Hematopoietic Stem Cell Transplantation - Review].
    Wang L; Gao R; Liu SF; Gao CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):302-306. PubMed ID: 29397863
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Gut toxicity during hemopoietic stem cell transplantation may predict acute graft-versus-host disease severity in patients.
    Johansson JE; Ekman T
    Dig Dis Sci; 2007 Sep; 52(9):2340-5. PubMed ID: 17415646
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Microbiome-Derived Metabolites in Allogeneic Hematopoietic Stem Cell Transplantation.
    Masetti R; Zama D; Leardini D; Muratore E; Turroni S; Brigidi P; Pession A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530464
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Butyrogenic and Lactic Bacteria of the Gut Microbiota Determine the Outcome of Allogenic Hematopoietic Cell Transplant.
    Devaux CA; Million M; Raoult D
    Front Microbiol; 2020; 11():1642. PubMed ID: 32793150
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation.
    Shouval R; Eshel A; Dubovski B; Kuperman AA; Danylesko I; Fein JA; Fried S; Geva M; Kouniavski E; Neuman H; Armon-Omer A; Shahien R; Muller E; Noecker C; Borenstein E; Louzoun Y; Nagler A; Koren O
    Blood Adv; 2020 Jul; 4(13):2912-2917. PubMed ID: 32598476
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease.
    Biliński J; Jasiński M; Basak GW
    Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453587
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease.
    Swimm A; Giver CR; DeFilipp Z; Rangaraju S; Sharma A; Ulezko Antonova A; Sonowal R; Capaldo C; Powell D; Qayed M; Kalman D; Waller EK
    Blood; 2018 Dec; 132(23):2506-2519. PubMed ID: 30257880
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms.
    Nguyen CL; Docampo MD; van den Brink MR; Markey KA
    Curr Opin Genet Dev; 2021 Feb; 66():25-35. PubMed ID: 33388483
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.
    Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T
    J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation.
    Seike K; Kiledal A; Fujiwara H; Henig I; Burgos da Silva M; van den Brink MRM; Hein R; Hoostal M; Liu C; Oravecz-Wilson K; Lauder E; Li L; Sun Y; Schmidt TM; Shah YM; Jenq RR; Dick G; Reddy P
    Immunity; 2023 Feb; 56(2):353-368.e6. PubMed ID: 36736321
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Metabolic Reprogramming-A New Era How to Prevent and Treat Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Has Begun.
    Kumari R; Palaniyandi S; Hildebrandt GC
    Front Pharmacol; 2020; 11():588449. PubMed ID: 33343357
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Fecal Microbiota Transfer in Acute Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation.
    Weber D; Meedt E; Poeck H; Thiele-Orberg E; Hiergeist A; Gessner A; Holler E
    Visc Med; 2024 Mar; 40(4):1-6. PubMed ID: 39047173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.